What is a peptide, exactly?

When I first started researching peptides I kept hitting the same wall: articles would drop terms like "half-life" and "bioavailability" and "receptor agonist" without explaining what any of them meant. So you would come away knowing the name of a compound but having no real understanding of what it actually does or why.

This post is the foundation. The vocabulary. The "before you read anything else, read this" piece.

Start here: amino acids

Your body runs on proteins. Proteins do everything, they are enzymes, structural components, hormones, signaling molecules, receptors. And proteins are made of amino acids.

Think of amino acids as letters. There are 20 standard ones the body uses. String letters together and you get words, that is a peptide. String words together into paragraphs and you get a protein.

The technical definition: a peptide is a chain of 2 to ~50 amino acids linked together by peptide bonds. A protein is typically longer than 50 amino acids, though the line is fuzzy. BPC-157 is 15 amino acids. A peptide. Hemoglobin is thousands of amino acids. A protein.

What a peptide bond actually is

When two amino acids link together, the bond formed is a peptide bond. A covalent connection between the carboxyl group of one amino acid and the amino group of the next. This is what gives a peptide its chain-like structure.

Here is why this matters practically: peptide bonds can be broken by enzymes called peptidases and proteases. Your digestive system is full of them. When you swallow most peptides, your gut breaks them apart into individual amino acids before they reach the bloodstream, which is why most research peptides cannot be taken orally. The structure gets destroyed before it can do anything.

This is why compounds like BPC-157 and TB-500 are typically injected subcutaneously (under the skin). Bypassing the digestive system means the peptide reaches circulation intact.

Half-life: how long it stays active

Half-life is the time it takes for half of a compound to be cleared from the body. A peptide with a 2-minute half-life (like natural GLP-1) is gone almost immediately. A compound like semaglutide, engineered to resist enzymatic breakdown and bind to albumin, has a half-life of about a week.

Half-life determines dosing frequency. Short half-life = needs to be used more often. Longer half-life = once weekly or less frequent. Most naturally occurring peptides have very short half-lives, which is why the research interest in synthetic analogues focuses heavily on extending stability.

Bioavailability: how much actually gets absorbed

Bioavailability is the fraction of a compound that reaches systemic circulation in an active form. Oral bioavailability for most peptides is near zero, the gut destroys them. Subcutaneous injection typically produces 70-90% bioavailability. Intravenous injection is 100% by definition.

Some peptides have been engineered for oral delivery (Rybelsus, the oral semaglutide tablet, uses a special absorption enhancer). But these are exceptions, most peptides in research require injection to be bioavailable.

Why are peptides interesting for research?

A few reasons they have attracted serious scientific and pharmaceutical attention:

• Specificity. Peptides can be designed to bind very precisely to specific receptors or enzymes. That specificity means targeted action with (potentially) fewer off-target effects than small molecules.
• Your body already makes them. Many research peptides are synthetic versions of endogenous (naturally occurring) peptides. GLP-1, BPC-157's parent sequence, Thymosin Beta-4. They are working within signaling systems the body already uses.
• The drug pipeline is real. Semaglutide and tirzepatide are peptides. They are multi-billion dollar drugs. The pharmaceutical industry has validated that peptide drugs can work at scale, which has driven enormous research interest in adjacent compounds.

Questions I get asked